Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cardiomyopathy

Alnylam's Hot Streak Cools As Expert Questions Uptake For Its Heart Drug

Alnylam stock cooled Friday as one expert argued the company will have to run a second study of its cardiomyopathy drug to gain traction.

Investors Business Daily

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ:MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns. MediWound shares traded in a range of $1.6 to $1.76 on a day…

Benzinga

Alnylam Pharmaceuticals Scores 'Clean Hit' In Closely Watched Heart Study, And Hits A Record

Alnylam stock hit a record high Wednesday after the company reported a "clean hit" for its Pfizer rival cardiomyopathy drug.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

How canine heart disease was tied to grain-free dog food

In 2018, the FDA began investigating whether the increasing popularity of grain-free dog foods had led to a sudden rise in a potentially fatal heart disease in dogs

The Independent UK

You really can die of sadness – and also happiness

Dying of a broken heart was just a figure of speech until 2002 when Dr Hikaru Sato and colleagues at Hiroshima City Hospital described it in a study. Sato named the condition takotsubo cardiomyopathy. It was quickly dubbed “broken heart syndrome”.

The Conversation

Recruits wanted for research into treatment for ‘broken heart syndrome’

Researchers at the University of Aberdeen are examining takotsubo cardiomyopathy.

The Independent UK

Yes, you can die of a "broken heart"

Intense grief seems to be connected to a condition that causes the heart to inexplicably shut down

Salon

Read news from The Economist, FT, and more,
with one subscription

Fetterman says he ‘almost died,’ but cardiologist says his prognosis, despite ignoring medical advice, is now good

PHILADELPHIA — A cardiologist who examined Pennsylvania Lt. Gov. John Fetterman after his stroke last month said Friday the Democratic Senate nominee has a type of cardiomyopathy, a heart disease that makes it harder for the heart to pump blood to the rest of the body. He said the pacemaker-defibrillator…

The Philadelphia Inquirer

Fetterman’s cardiologist said the Pa. Senate candidate ignored medical advice, but his prognosis is good

PHILADELPHIA — A cardiologist who examined Pennsylvania Lt. Gov. John Fetterman after his stroke said the Democratic Senate nominee has a type of cardiomyopathy, a heart disease that makes it harder for the heart to pump blood to the rest of the body. He said the pacemaker-defibrillator Fetterman received, along…

The Philadelphia Inquirer

Doctor: Pennsylvania's Fetterman also has cardiomyopathy

The cardiologist for John Fetterman, the Democratic nominee for U.S. Senate in Pennsylvania who is recovering from a stroke, has disclosed that Fetterman also has cardiomyopathy

The Independent UK

Can you die of a broken heart? Takotsubo cardiomyopathy explained

Many may have heard of broken-heart syndrome but aren't sure what it is - here are the key facts about the condition.

Daily Record

What is broken heart syndrome?

The condition is also known as Takutsubo cardiomyopathy

The Independent UK

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

British Heart Foundation

278 stories

ROBB ELEMENTARY SCHOOL

113 stories

European Medicines Agency

75 stories

Tufts

56 stories

University of Aberdeen

52 stories

Alnylam Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.